The Arizona Bioindustry Association will honor Marvin J. Slepian, MD, of the University of Arizona with the AZBio Pioneer Award for Lifetime Achievement at the 2017 AZBio Awards. Arizona life science and business leaders, as well as guests from across the country, will be on hand to applaud Dr. Slepian for a body of work that has made life better for people at home and around the world.
Continue reading
Category Archives: AZBio News
GlobalMed Telehealth Technology featured in VA Video Connect Announcement
Telehealth Technology developed and delivered by Scottsdale, Arizona based GlobaMed was demonstrated when President Donald Trump and , VA secretary Dr. David J. Shulkin announced the Veteran telehealth initiatives designed to provide greater access, care.
Apply for the Fall 2017 Arizona Innovation Challenge
Get Ready To Accept The Challenge !!Continue reading
FDA User Fee Package On Its Way to the President
On Thursday August 3rd, the Senate passed HR2430, the FDA Reauthorization Act of 2017. The bill now moves to President Trump for signature. Continue reading
Insys Announces Availability of SYNDROS, the First and Only FDA-Approved Liquid Dronabinol, by Prescription
PHOENIX, July 31, 2017 (GLOBE NEWSWIRE) — Insys Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the Company”) today announced that SYNDROS™ (dronabinol oral solution), a proprietary, orally administered liquid formulation of dronabinol, CII, is now available for health care professionals to prescribe.
KEYS Program Pairs Young Scientists With UA Research Mentors
Nothing compares to the hands-on lab experience, say the high school students, many of whom decide to continue their studies as undergraduates at The University of Arizona.
HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN
HTG is Developing NGS Gene Expression Profiling Assays for Multiple Cancer TherapiesContinue reading
Living computers: RNA circuits transform cells into nanodevices
ASU Biodesign researcher shows how cells can be induced to carry out computations — with implications in health and energy.Continue reading
Paradigm Announces Major Price Reduction in Flagship Paradigm Cancer Diagnostic (PCDx)
On July 24, 2017, Paradigm Diagnostics announced a major price reduction of PCDx. “The efficiency of our proprietary process and transition to an optimized platform enables us to share the savings with our patients, customers, research partners, and distributors without impacting our industry leading accuracy, speed, and comprehensiveness,” said David Mallery, CEO.